The NIFTY50 index declined by 6.06% in September 2026, closing at 22,620.45 points on September 30. Despite this overall drop, three stocks—Coal India, Adani Ports & SEZ, and Dr Reddy’s Laboratories—showed gains of up to 13% during the month. This contrast highlights how certain sectors and companies performed well amid broader market challenges.
- The NIFTY50 index lost 6.06% in September 2026.
- Coal India shares rose nearly 6% due to improved production and supply.
- Adani Ports & SEZ shares gained nearly 13%, aided by a settlement with SEBI and new contracts.
- Dr Reddy’s Laboratories shares increased about 7%, supported by new partnerships and sector growth potential.
- Market volatility was influenced by US Treasury yields, crude oil prices, and geopolitical tensions.
Why did the NIFTY50 index fall in September 2026?
The NIFTY50 index dropped by 6.06% in September 2026 due to several factors. Investors were cautious because of foreign fund outflows and a volatile global environment. The US benchmark Treasury yields reached multi-year highs, increasing borrowing costs and affecting investor sentiment.
Additionally, Brent crude oil prices surged more than 17% amid concerns about energy supply disruptions, especially with no signs of reopening the Strait of Hormuz. Geopolitical tensions, including the US President rejecting Iran’s peace proposal related to the West Asia conflict, added to market uncertainty and volatility.
What helped Coal India shares gain in September?
Coal India shares outperformed the market by gaining nearly 6% in September. This rise was driven by improved production and supply figures. For example, Northern Coalfields, a major Coal India subsidiary, recorded a 67% increase in production and a 75% increase in supply as of September 8 compared to early September averages.
Coal India reported that average daily coal production rose by 40%, from 1.36 million tonnes per day during early September to 1.91 million tonnes on September 8. The company also signed a non-binding memorandum of understanding with Hindustan Urvarak & Rasayan Limited to explore coal gasification-based urea production, signaling potential future growth.
How did Dr Reddy’s Laboratories perform and why?
Dr Reddy’s Laboratories shares gained about 7% in September, outperforming the NIFTY50 index. The company entered into an agreement with Takeda Biopharmaceuticals India Private Limited to distribute and market the dengue vaccine Qdenga® in India’s private market. This partnership aims to strengthen Dr Reddy’s vaccines business and support public health efforts against dengue.
Additionally, Dr Reddy’s expanded its collaboration with Gilead Sciences through a voluntary licensing agreement for an investigational once-yearly HIV prevention drug. These developments, along with the defensive nature of healthcare stocks, attracted investor interest.
The company’s board planned to meet on October 23, 2026, to approve financial results for the quarter ending September 30, which investors awaited closely.
What factors influenced Adani Ports & SEZ’s stock rise?
Adani Ports & SEZ shares gained nearly 13% in September, significantly outperforming the NIFTY50 index. This rise followed a settlement with the Securities and Exchange Board of India (SEBI) over alleged violations of minimum public shareholding norms. The company paid a settlement amount of ₹37,05,000.
Moreover, Adani Ports received a Letter of Award to develop and operate two dry bulk berths at Paradip Port, Odisha, for 30 years through a competitive bidding process. This new contract added to positive investor sentiment about the company’s growth prospects.
What are the key takeaways from September’s market performance?
- The NIFTY50 index fell due to global economic factors and geopolitical tensions.
- Energy and infrastructure sectors showed resilience, with Coal India and Adani Ports gaining.
- Healthcare stocks like Dr Reddy’s benefited from strategic partnerships and sector growth potential.
- Investors remained cautious but found opportunities in select stocks amid market volatility.
